-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Improving Systems-Level Management of Anticoagulants Within and Across Care Settings

Program: Special-Interest Sessions
Session: Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management
Hematology Disease Topics & Pathways:
Anticoagulant Drugs, Clinical Practice (Health Services and Quality), Workforce, Treatment Considerations, Non-Biological therapies, Technology and Procedures
Sunday, December 8, 2024, 4:30 PM-6:30 PM

Geoffrey D Barnes, MD, MSc

Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, MI

Disclosures: Barnes: Pfizer: Consultancy; Anticoagulation Forum: Membership on an entity's Board of Directors or advisory committees; Boston Scientific: Consultancy, Research Funding; Abbott Vascular: Consultancy; Anthos: Consultancy; NHLBI: Research Funding; Bristol Myers Squibb: Consultancy; Blue Cross Blue Shield of Michigan: Research Funding; Janssen: Consultancy; Bayer: Consultancy; Sanofi: Consultancy.

See more of: Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management
See more of: Special-Interest Sessions
Previous Presentation | Next Presentation >>